Related Articles

  • Review ArticleJune 30, 2022

    0 253 460

    Direct Oral Anticoagulants for Anticoagulation after Initial Management of Venous Thromboembolism

    Se Min Ryu, M.D., Ph.D., Sung-Min Park, M.D., Ph.D., Se-Ran Yang, D.V.M., Ph.D., Seong-Joon Cho, M.D., Ph.D., Sook Won Ryu, M.D., Ph.D. and Seung-Hwan Lee, M.D., Ph.D.

    Ann Phlebology 2022; 20(1): 9-14
    Direct oral anticoagulants for the long-term treatment of venous thromboembolisms including deep vein thrombosis and pulmonary embolism are preferred for most hemodynamically stable, non-pregnant patients who do not have severe renal insufficiency or active cancer. This preference for these medications is based on their comparable efficacy, reduced need for monitoring, and safety profile, especially when compared to warfarin in terms of major bleeding. Recent studies suggest that certain direct oral anticoagulants may be advantageous over others.
  • Review ArticleJune 30, 2022

    0 936 2598

    Surgical Embolectomy of Acute Pulmonary Embolism

    Tae Sik Kim, M.D., Ph.D.

    Ann Phlebology 2022; 20(1): 15-18
    Treatment for acute pulmonary embolism includes anticoagulation, thrombolysis, catheter-directed therapy, and surgical pulmonary embolectomy. Surgical embolectomy is indicated in select patients based on a risk/benefit assessment and when other treatment options are contraindicated. A multidisciplinary approach along with a meticulous surgical technique might significantly lower the mortality associated with surgical embolectomy.
AP
Vol.22 No.2 Dec 31, 2024, pp. 39~93

Most Keyword ?

What is Most Keyword?

  • It is the most frequently used keyword in articles in this journal for the past two years.

Most Read

Annals of Phlebology